How a large-cap pharma in the Direct Oral Anticoagulant Space (DOAC) space updated its promotional tactics to regain lost SoV
The Challenge: Stimulating conversation around your brand when your competitors…
How a large pharma in Hematology and Oncology space established and used competitive benchmarks across the US
The Challenge: Knowing field force performance against the competition A large…
How a leading global player in the respiratory space worked towards speedier access to Russia and China
The Challenge: Leading multinational Pharma company wants to dive deep into key…
How we helped a mid-size Pharma in the primary immunodeficiency (PID) space to respond successfully to a competitor's move.
The Challenge: Dealing with an existing competitor launching a new product.…
Do you want to gain insights into the CVC portfolios of 19 Biopharma Companies and Google? Then read below!
Over the past few years, corporate venture capital (CVC) companies backed by or…
Gene therapy treatments for Inherited Retinal Disorders (IRD) hold great promise.
Globally 4.5 million people are affected by IRDs — a group of diseases having a…
AAV-based gene therapies: Safe or not? Challenges and considerations for the future.
Adeno-associated virus (AAV) is one of the most studied gene therapy vehicles.…
Decentralized Clinical Trials (DCTs) in Oncology – Is the Pharma Industry ready?
The acceptance of telehealth and the incorporation of digital technologies have…
Metaverse and Healthcare: prepare to enter the Matrix!
No matter how hard it is to believe, we see a concept from a sci-fi movie…
Emerging trends in Hemophilia management. Is it time to say goodbye to standard CFC replacement therapy?
What is hemophilia? Hemophilia is a rare X-linked congenital bleeding disorder.…
Precision medicines: a value-based approach
Precision medicine is a novel and targeted approach for disease treatment and…
Value-based healthcare, a new reality for everyone!
One of the biggest challenges in global healthcare is the rapidly increasing…